Priser
Platform
Blog
Om os
Download
Metrovacesa
Metrovacesa
Bolsa de Madrid
0

Om

Metrovacesa S.A. is a prominent Spanish real estate company specializing in the development and sale of residential properties on land designated for urban development. Its primary operations center on the residential segment, which generates the majority of its revenue, alongside smaller commercial and other activities, predominantly within Spain. The company focuses on transforming suitable land into housing projects, contributing to the residential real estate market by addressing demand for new homes. Notable features include a strong emphasis on land banks classified for development, a workforce of approximately 223 employees, and leadership under CEO Jorge Pérez de Leza Eguiguren. Metrovacesa S.A. plays a significant role in Spain's real estate sector, classified as a small growth stock in real estate development, with financial metrics reflecting its position in a cyclical industry influenced by housing market trends, economic conditions, and regulatory environments.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I METROVACESA MED ENDAVU: Køb Metrovacesa ($MVC) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Metrovacesa, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerMVC
Land
Spanien
Antal medarbejdere214
Hjemmesidemetrovacesa.com
SektorEjendomme
IndustriEjendomsudvikling

Udbytter

0,8EUR
'21
1,65EUR
'22
0,66EUR
'23
0,69EUR
'24
1,58EUR
'25
Ex-udbytte-dato19. dec. 2025
Udbytteafkast13,12%

Analytikerskøn

Baseret på 5 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%0%60%20%20%